Discovery of a potent and selective GPR120 agonist (original) (raw)

Shimpukade, B., Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Hogaard, C.K., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, T.(2012) Discovery of a potent and selective GPR120 agonist.Journal of Medicinal Chemistry, 55(9), pp. 4511-4515. (doi: 10.1021/jm300215x)

Full text not currently available from Enlighten.

Abstract

GPR120 is a receptor of unsaturated long-chain fatty acids reported to mediate GLP-1 secretion, insulin sensitization, anti-inflammatory, and anti-obesity effects and is therefore emerging as a new potential target for treatment of type 2 diabetes and metabolic diseases. Further investigation is however hindered by the lack of suitable receptor modulators. Screening of FFA1 ligands provided a lead with moderate activity on GPR120 and moderate selectivity over FFA1. Optimization led to the discovery of the first potent and selective GPR120 agonist.

Item Type: Articles
Status: Published
Refereed: Yes
Glasgow Author(s) Enlighten ID: Hudson, Dr Brian and Milligan, Professor Graeme
Authors: Shimpukade, B., Hudson, B.D., Hogaard, C.K., Milligan, G., and Ulven, T.
Subjects: Q Science > QD Chemistry
College/School: College of Medical Veterinary and Life Sciences > School of Molecular Biosciences
Journal Name: Journal of Medicinal Chemistry
ISSN: 0022-2623
Published Online: 23 April 2012

University Staff: Request a correction | Enlighten Editors: Update this record